Lactococcus cremoris YRC3780 improves subjective sleep quality in adults with sleep dissatisfaction: A randomized double-blind placebo-controlled study
Ikumi Fujioka, Kenji UchidaBackground
Aim
We examined the effects of YRC3780 in subjects dissatisfied with their sleep.
Methods
We investigated the effects of daily YRC3780 intake for 8 weeks on sleep in a randomized, placebo-controlled, double-blind, parallel-group study involving 105 healthy Japanese adults with baseline Athens Insomnia Scale (AIS) scores of ≥6.
Summary
After 8 weeks, the AIS score and the change from baseline score were significantly better in the YRC3780 group than in the placebo group. The YRC3780 group showed significant improvements compared with the placebo group in the scores for the individual AIS items related to “sleep induction” at 4 weeks and in those for “functioning capacity during the day” at 8 weeks. The percentage changes from baseline at 4 weeks for the Oguri–Shirakawa–Azumi Sleep Inventory Middle-aged and Aged version question “fell asleep quickly” and for the Japanese version of the Epworth Sleepiness Scale question about sleepiness while watching TV were significantly better in the YRC3780 group than in the placebo group. In conclusion, daily YRC3780 intake significantly improved sleep quality and alleviated daytime sleepiness and difficulty falling asleep in healthy Japanese adults with sleep complaints (UMIN-CTR,